Interestingly, in a recent study using resistant colon cancer stem-like cells and mouse models, combination therapy of regorafenib with two antagonists of IGF-1-R, namely aspirin and the selective dual insulin receptor and IGF-1R kinase inhibitor linsitinib (OSI-906), abrogated tumor resistance to regorafenib and restored the drugs ability to induce apoptosis in colon cancer stem-like cells and disease activity index (51)
When injecting, go slowly and steadily, keeping the needle still while its in your skin
Reported by Park Ha-jeong | Video by Yoon Tae-ho | VJ by Shin So-young and Oh Se-gwan | Graphics by Han Heung-soo Please note: This article was translated by AI and may contain errors
Some studies report benefits at 1,800mg per day, but long-term safety data at these levels are limited.37 Is ALA supplementation safe
Pros: Inexpensive, widely available